Factors in the pathogenesis of experimental nonketotic and ketoacidotic diabetic stupor

B. I. Joffe, H. C. Seftel, Ronald B Goldberg, M. Van As, L. Krut, I. Bersohn

Research output: Contribution to journalArticle

8 Citations (Scopus)

Abstract

In an attempt to elucidate some of the factors responsible for the absence of significant ketosis in hyperosmolar nonketotic diabetic stupor, an experimental model was created in rats. This involved the intravenous administration of alloxan (40 mg per kg) to produce moderate hyperglycemia, followed by daily hydrocortisone injections and dextrose feeding. For comparison, ketoacidotic diabetic rats and various control situations were also studied. The biochemical profiles of the nonketotic and ketoacidotic diabetic rats resembled those of their clinical counterparts, although some discrepancies were apparent. Attention was directed at measuring plasma free fatty acid (FFA) and ketone body levels, as well as hepatic glycogen and portal and peripheral plasma immunoreactive insulin (IRI) concentrations in the diabetic and control groups. The hyperosmolar nonketotic diabetic rats were characterized by: a mean plasma FAA level intermediate between that of the controls and that of the ketotics; modest rises in 3 hydroxybutyrate and acetoacetate; and a striking elevation in hepatic glycogen concentration. In addition, their mean portal IRI value resembled that of the control rats (both significantly greater than ketotics) but their mean peripheral plasma IRI value was similar to that of the ketotics (both significantly lower than controls). It is suggested that the absence of severe ketosis in the hyperosmolar nonketotic diabetic rats was, at least in part, due to the ability of their glycogen rich, 'insulinized' livers to metabolize incoming FFA largely along nonketogenic pathways. The relevance of these findings to the clinical situation is briefly considered.

Original languageEnglish
Pages (from-to)653-657
Number of pages5
JournalDiabetes
Volume22
Issue number9
StatePublished - Dec 1 1973
Externally publishedYes

Fingerprint

Stupor
Liver Glycogen
Ketosis
Insulin
Nonesterified Fatty Acids
Ketone Bodies
Alloxan
3-Hydroxybutyric Acid
Glycogen
Hyperglycemia
Intravenous Administration
Hydrocortisone
Theoretical Models
Glucose
Control Groups
Injections
Liver

ASJC Scopus subject areas

  • Internal Medicine
  • Endocrinology, Diabetes and Metabolism

Cite this

Joffe, B. I., Seftel, H. C., Goldberg, R. B., Van As, M., Krut, L., & Bersohn, I. (1973). Factors in the pathogenesis of experimental nonketotic and ketoacidotic diabetic stupor. Diabetes, 22(9), 653-657.

Factors in the pathogenesis of experimental nonketotic and ketoacidotic diabetic stupor. / Joffe, B. I.; Seftel, H. C.; Goldberg, Ronald B; Van As, M.; Krut, L.; Bersohn, I.

In: Diabetes, Vol. 22, No. 9, 01.12.1973, p. 653-657.

Research output: Contribution to journalArticle

Joffe, BI, Seftel, HC, Goldberg, RB, Van As, M, Krut, L & Bersohn, I 1973, 'Factors in the pathogenesis of experimental nonketotic and ketoacidotic diabetic stupor', Diabetes, vol. 22, no. 9, pp. 653-657.
Joffe BI, Seftel HC, Goldberg RB, Van As M, Krut L, Bersohn I. Factors in the pathogenesis of experimental nonketotic and ketoacidotic diabetic stupor. Diabetes. 1973 Dec 1;22(9):653-657.
Joffe, B. I. ; Seftel, H. C. ; Goldberg, Ronald B ; Van As, M. ; Krut, L. ; Bersohn, I. / Factors in the pathogenesis of experimental nonketotic and ketoacidotic diabetic stupor. In: Diabetes. 1973 ; Vol. 22, No. 9. pp. 653-657.
@article{a8a48dd906334db092d7ce190fefda6e,
title = "Factors in the pathogenesis of experimental nonketotic and ketoacidotic diabetic stupor",
abstract = "In an attempt to elucidate some of the factors responsible for the absence of significant ketosis in hyperosmolar nonketotic diabetic stupor, an experimental model was created in rats. This involved the intravenous administration of alloxan (40 mg per kg) to produce moderate hyperglycemia, followed by daily hydrocortisone injections and dextrose feeding. For comparison, ketoacidotic diabetic rats and various control situations were also studied. The biochemical profiles of the nonketotic and ketoacidotic diabetic rats resembled those of their clinical counterparts, although some discrepancies were apparent. Attention was directed at measuring plasma free fatty acid (FFA) and ketone body levels, as well as hepatic glycogen and portal and peripheral plasma immunoreactive insulin (IRI) concentrations in the diabetic and control groups. The hyperosmolar nonketotic diabetic rats were characterized by: a mean plasma FAA level intermediate between that of the controls and that of the ketotics; modest rises in 3 hydroxybutyrate and acetoacetate; and a striking elevation in hepatic glycogen concentration. In addition, their mean portal IRI value resembled that of the control rats (both significantly greater than ketotics) but their mean peripheral plasma IRI value was similar to that of the ketotics (both significantly lower than controls). It is suggested that the absence of severe ketosis in the hyperosmolar nonketotic diabetic rats was, at least in part, due to the ability of their glycogen rich, 'insulinized' livers to metabolize incoming FFA largely along nonketogenic pathways. The relevance of these findings to the clinical situation is briefly considered.",
author = "Joffe, {B. I.} and Seftel, {H. C.} and Goldberg, {Ronald B} and {Van As}, M. and L. Krut and I. Bersohn",
year = "1973",
month = "12",
day = "1",
language = "English",
volume = "22",
pages = "653--657",
journal = "Diabetes",
issn = "0012-1797",
publisher = "American Diabetes Association Inc.",
number = "9",

}

TY - JOUR

T1 - Factors in the pathogenesis of experimental nonketotic and ketoacidotic diabetic stupor

AU - Joffe, B. I.

AU - Seftel, H. C.

AU - Goldberg, Ronald B

AU - Van As, M.

AU - Krut, L.

AU - Bersohn, I.

PY - 1973/12/1

Y1 - 1973/12/1

N2 - In an attempt to elucidate some of the factors responsible for the absence of significant ketosis in hyperosmolar nonketotic diabetic stupor, an experimental model was created in rats. This involved the intravenous administration of alloxan (40 mg per kg) to produce moderate hyperglycemia, followed by daily hydrocortisone injections and dextrose feeding. For comparison, ketoacidotic diabetic rats and various control situations were also studied. The biochemical profiles of the nonketotic and ketoacidotic diabetic rats resembled those of their clinical counterparts, although some discrepancies were apparent. Attention was directed at measuring plasma free fatty acid (FFA) and ketone body levels, as well as hepatic glycogen and portal and peripheral plasma immunoreactive insulin (IRI) concentrations in the diabetic and control groups. The hyperosmolar nonketotic diabetic rats were characterized by: a mean plasma FAA level intermediate between that of the controls and that of the ketotics; modest rises in 3 hydroxybutyrate and acetoacetate; and a striking elevation in hepatic glycogen concentration. In addition, their mean portal IRI value resembled that of the control rats (both significantly greater than ketotics) but their mean peripheral plasma IRI value was similar to that of the ketotics (both significantly lower than controls). It is suggested that the absence of severe ketosis in the hyperosmolar nonketotic diabetic rats was, at least in part, due to the ability of their glycogen rich, 'insulinized' livers to metabolize incoming FFA largely along nonketogenic pathways. The relevance of these findings to the clinical situation is briefly considered.

AB - In an attempt to elucidate some of the factors responsible for the absence of significant ketosis in hyperosmolar nonketotic diabetic stupor, an experimental model was created in rats. This involved the intravenous administration of alloxan (40 mg per kg) to produce moderate hyperglycemia, followed by daily hydrocortisone injections and dextrose feeding. For comparison, ketoacidotic diabetic rats and various control situations were also studied. The biochemical profiles of the nonketotic and ketoacidotic diabetic rats resembled those of their clinical counterparts, although some discrepancies were apparent. Attention was directed at measuring plasma free fatty acid (FFA) and ketone body levels, as well as hepatic glycogen and portal and peripheral plasma immunoreactive insulin (IRI) concentrations in the diabetic and control groups. The hyperosmolar nonketotic diabetic rats were characterized by: a mean plasma FAA level intermediate between that of the controls and that of the ketotics; modest rises in 3 hydroxybutyrate and acetoacetate; and a striking elevation in hepatic glycogen concentration. In addition, their mean portal IRI value resembled that of the control rats (both significantly greater than ketotics) but their mean peripheral plasma IRI value was similar to that of the ketotics (both significantly lower than controls). It is suggested that the absence of severe ketosis in the hyperosmolar nonketotic diabetic rats was, at least in part, due to the ability of their glycogen rich, 'insulinized' livers to metabolize incoming FFA largely along nonketogenic pathways. The relevance of these findings to the clinical situation is briefly considered.

UR - http://www.scopus.com/inward/record.url?scp=0015821504&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0015821504&partnerID=8YFLogxK

M3 - Article

C2 - 4199491

AN - SCOPUS:0015821504

VL - 22

SP - 653

EP - 657

JO - Diabetes

JF - Diabetes

SN - 0012-1797

IS - 9

ER -